Inhibitory potential of probiotic strains against pathogens associated with osteomyelitis of the jaws: a quantitative MIC and MBC analysis.

IF 1.5 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Moayad Baazeem, Abdurahman Niazy, Sameh Rabea, Abdulaziz A Alomiery
{"title":"Inhibitory potential of probiotic strains against pathogens associated with osteomyelitis of the jaws: a quantitative MIC and MBC analysis.","authors":"Moayad Baazeem, Abdurahman Niazy, Sameh Rabea, Abdulaziz A Alomiery","doi":"10.14715/cmb/2025.71.6.9","DOIUrl":null,"url":null,"abstract":"<p><p>Osteomyelitis of the jaw is a significant health burden, often associated with biofilm formation, antimicrobial resistance, and complex bacterial interactions. This study aimed to evaluate the antibacterial efficacy of two probiotic strains, Lactobacillus reuteri DSM 17938 and ATCC PTA 6475, against three key pathogens: Fusobacterium nucleatum, Actinomyces israelii, and Staphylococcus aureus. The focus was on their potential as adjunctive treatments for osteomyelitis of the jaws. This in-vitro study employed tailored standard protocols to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the probiotic strains against the tested pathogens. Probiotic suspensions were prepared in serial dilutions and bacterial strains were inoculated into brain heart infusion media for exposure. The growth inhibition and eradication were confirmed through subculture techniques and microscopic examination of Gram-stained samples. Both probiotic strains exhibited significant antibacterial activity against Fusobacterium nucleatum and Actinomyces israelii at low concentrations, achieving MIC of 0.625 µl and MBC of 1.25 µl for both pathogens. In contrast, Staphylococcus aureus demonstrated greater resistance, with MIC and MBC recorded at 100 µl and 200 µl, respectively. The differential response underscores the variable susceptibility of bacterial species to probiotics and highlights the potential for selective therapeutic application. Within the scope of this study, two Lactobacillus reuteri strains demonstrated promising antibacterial effects against Fusobacterium nucleatum and Actinomyces israelii, suggesting their potential utility in managing osteomyelitis of the jaws. However, higher concentrations or synergistic approaches may be needed to combat Staphylococcus aureus. Further studies including preclinical and clinical trials are essential to translate these findings into effective therapeutic strategies.</p>","PeriodicalId":9802,"journal":{"name":"Cellular and molecular biology","volume":"71 6","pages":"68-74"},"PeriodicalIF":1.5000,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and molecular biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.14715/cmb/2025.71.6.9","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Osteomyelitis of the jaw is a significant health burden, often associated with biofilm formation, antimicrobial resistance, and complex bacterial interactions. This study aimed to evaluate the antibacterial efficacy of two probiotic strains, Lactobacillus reuteri DSM 17938 and ATCC PTA 6475, against three key pathogens: Fusobacterium nucleatum, Actinomyces israelii, and Staphylococcus aureus. The focus was on their potential as adjunctive treatments for osteomyelitis of the jaws. This in-vitro study employed tailored standard protocols to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the probiotic strains against the tested pathogens. Probiotic suspensions were prepared in serial dilutions and bacterial strains were inoculated into brain heart infusion media for exposure. The growth inhibition and eradication were confirmed through subculture techniques and microscopic examination of Gram-stained samples. Both probiotic strains exhibited significant antibacterial activity against Fusobacterium nucleatum and Actinomyces israelii at low concentrations, achieving MIC of 0.625 µl and MBC of 1.25 µl for both pathogens. In contrast, Staphylococcus aureus demonstrated greater resistance, with MIC and MBC recorded at 100 µl and 200 µl, respectively. The differential response underscores the variable susceptibility of bacterial species to probiotics and highlights the potential for selective therapeutic application. Within the scope of this study, two Lactobacillus reuteri strains demonstrated promising antibacterial effects against Fusobacterium nucleatum and Actinomyces israelii, suggesting their potential utility in managing osteomyelitis of the jaws. However, higher concentrations or synergistic approaches may be needed to combat Staphylococcus aureus. Further studies including preclinical and clinical trials are essential to translate these findings into effective therapeutic strategies.

益生菌菌株对颌骨骨髓炎相关病原体的抑制潜力:定量MIC和MBC分析。
颌骨骨髓炎是一种严重的健康负担,通常与生物膜形成、抗菌素耐药性和复杂的细菌相互作用有关。本研究旨在评价两种益生菌——罗伊氏乳杆菌DSM 17938和ATCC PTA 6475对核梭菌、以色列放线菌和金黄色葡萄球菌的抑菌效果。重点是它们作为颌骨骨髓炎辅助治疗的潜力。本体外研究采用量身定制的标准方案来确定益生菌菌株对被测病原体的最低抑菌浓度(MIC)和最低杀菌浓度(MBC)。制备连续稀释的益生菌悬浮液,将菌株接种于脑心输注培养基中暴露。通过继代培养技术和革兰氏染色样品的显微镜检查证实了生长抑制和根除。两株益生菌在低浓度下对核梭杆菌和以色列放线菌均表现出显著的抑菌活性,对两种病原菌的MIC和MBC分别为0.625µl和1.25µl。相比之下,金黄色葡萄球菌表现出更大的耐药性,MIC和MBC分别为100µl和200µl。这种不同的反应强调了细菌种类对益生菌的不同敏感性,并强调了选择性治疗应用的潜力。在本研究范围内,两种罗伊氏乳杆菌菌株对核梭杆菌和以色列放线菌表现出良好的抗菌作用,表明它们在治疗颌骨骨髓炎方面的潜在效用。然而,可能需要更高的浓度或协同方法来对抗金黄色葡萄球菌。进一步的研究,包括临床前和临床试验,将这些发现转化为有效的治疗策略是必不可少的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cellular and molecular biology
Cellular and molecular biology 生物-生化与分子生物学
CiteScore
1.60
自引率
12.50%
发文量
331
期刊介绍: Cellular and Molecular Biology publishes original articles, reviews, short communications, methods, meta-analysis notes, letters to editor and comments in the interdisciplinary science of Cellular and Molecular Biology linking and integrating molecular biology, biophysics, biochemistry, enzymology, physiology and biotechnology in a dynamic cell and tissue biology environment, applied to human, animals, plants tissues as well to microbial and viral cells. The journal Cellular and Molecular Biology is therefore open to intense interdisciplinary exchanges in medical, dental, veterinary, pharmacological, botanical and biological researches for the demonstration of these multiple links.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信